Getting your Trinity Audio player ready...
Oct 9 (Reuters) – Astex Pharmaceuticals Inc :
* Says disappointed that Sarissa Capital continues to mislead
Astex
stockholders with information that is incomplete
* Says $8.50 per share all-cash transaction with Otsuka was in
the best
interests of all Astex stockholders
* Says no third parties have approached Astex with an interest
to acquire the
company
* Source text for Eikon
* Further company coverage
